We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£495.00
The 2023-2028 Outlook for Tyrosine Kinase Inhibitors in Japan
Price data last checked 41 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 50 days · 50 data points (no recent data)
Price Distribution
Price distribution over 50 days • 1 price levels
Price Analysis
Most common price: £495 (50 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 50 days
Product Specifications
- Format
- paperback
- ASIN
- B0BP9M9VQJ
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 28 November 2022
- Listed Since
- 08 December 2022
Similar Products You Might Like
The 2023-2028 Outlook for Tyrosine Kinase Inhibitors in the United States
The 2023-2028 Outlook for Tyrosine Kinase Inhibitors in India
The 2023-2028 Outlook for Digital Therapeutic (DTx) in Japan
The 2023-2028 Outlook for Digital Therapeutic (DTx) in China
The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in Latin America
The 2023-2028 Outlook for Personal Therapy Products in Japan
The 2013-2018 Outlook for Personal Therapy Products in Europe
The 2023-2028 Outlook for Brain Health Supplements in Japan
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in Japan
The 2023-2028 Outlook for Personal Therapy Products in China
The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in North America & the Caribbean
The 2013-2018 Outlook for Personal Therapy Products in Latin America
The 2011-2016 Outlook for Personal Therapy Products in Asia
The 2023-2028 Outlook for 4K Technologies in China
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in The Americas
The 2023-2028 Outlook for Ready to Drink Tea and Coffee in Japan
The 2023-2028 Outlook for Digital Therapeutics Sales in India
The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States
The 2023-2028 Outlook for Cognitive and Memory Enhancer Drugs in China
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in Greater China
The 2023-2028 Outlook for Cognition and Memory Enhancement Drugs in China
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan
